Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$77.00 – $152.00
1% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.42B | $2.67B | $3.12B | $3.38B | $3.59B | $3.67B | $3.98B | $4.07B |
| Cost of revenue | $1.12B | $1.21B | $1.36B | $1.41B | $1.58B | $1.62B | $1.76B | $1.76B |
| Gross profit | $1.30B | $1.47B | $1.75B | $2.00B | $2.01B | $2.06B | $2.22B | $2.27B |
| Gross margin | 53.8% | 54.8% | 56.2% | 59.3% | 56.0% | 56.0% | 55.7% | 55.9% |
| R&D | $326.9M | $374.3M | $398.8M | $389.0M | $446.6M | $540.3M | $491.5M | $507.2M |
| Operating income | $343.6M | $370.7M | $552.8M | $784.3M | $587.2M | $439.0M | $588.8M | $654.5M |
| EBITDA | $517.3M | $576.9M | $796.5M | $1.01B | $852.6M | $857.8M | $897.5M | $848.6M |
| Net income | $256.5M | $272.8M | $404.4M | $601.1M | $452.4M | $357.6M | $432.2M | $397.4M |
| Net margin | 10.6% | 10.2% | 13.0% | 17.8% | 12.6% | 9.7% | 10.9% | 9.8% |
| EPS (diluted) | 2.17 | 2.30 | 3.41 | 5.06 | 3.82 | 3.01 | 3.64 | 3.34 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $4.0B | $4.26 | $4.03–$4.41 | 2 |
| 2027 | $4.3B | $4.76 | $4.53–$4.99 | 2 |
| 2028 | $4.6B | $5.34 | $5.15–$5.45 | 1 |
| 2029 | $4.8B | $5.84 | $5.63–$5.96 | 1 |
Forward consensus · source: Financial Modeling Prep
BIOMERIEUX 69 MARCY NEW
No one on the platform currently holds BMXMF.
No tracked institution reports a position in BMXMF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-10 | $0.9800 | 2026-06-11 |
| 2025-06-10 | $0.9000 | 2025-06-11 |
| 2024-06-10 | $0.8500 | 2024-06-11 |
| Execution date | Ratio |
|---|---|
| 2017-09-21 | 3-for-1 |
No one on the platform has traded BMXMF yet.
| $10.9B |
| — |
| DHRDanaher Corporation | $190.88 | -0.99% | $135.1B | — |
| FONRFonar Corp. | $19.09 | +0.00% | $118M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 11.4× earnings vs its 31.9× historical median P/E.
Fair value ≈ $218.14 · price $77.93 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.